2013-2018年美国高危人群HBV感染、疫苗免疫及易感性患病率
该研究基于2013-2018年美国国家健康与营养调查数据,估计美国≥6岁非机构人员中HBV感染、疫苗免疫及易感性。结果显示慢性HBV感染患病率自1999年以来保持0.3%不变,非美国出生居民占慢性感染的69.1%,≥25岁成人中73.4%对HBV易感。
要点
- 慢性HBV感染患病率自1999年以来保持0.3%不变。
- 非美国出生居民占慢性HBV感染的69.1%,风险为美国出生者的9.1倍。
核心结论
- 尽管出生后接种疫苗的年轻人免疫保护增加,美国慢性HBV感染患病率自1999年以来仍保持0.3%不变。
研究设计与样本
- 基于2013-2018年美国国家健康与营养调查数据,对≥6岁非机构人员进行血清学检测的横断面研究。
主要发现
- 非美国出生居民占慢性HBV感染人群的69.1%,其慢性乙肝风险是美国出生者的9.1倍。
- 男男性行为者(MSM)曾感染HBV的风险为3.6倍,但疫苗诱导免疫与非MSM相当。
关键数值与推荐
- 总乙肝核心抗体(anti-HBc)阳性提示当前或既往HBV感染,HBsAg阳性提示当前感染,anti-HBs阳性提示疫苗诱导免疫。
- anti-HBc、HBsAg和anti-HBs均阴性者视为对HBV易感。
临床怎么用
- 应关注非美国出生居民和MSM等高危人群的HBV筛查与疫苗接种。
- 成人中对HBV易感者比例较高,需加强疫苗免疫策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: In the USA, HBV is one of the leading causes of chronic liver disease and cirrhosis and is a major cause of liver cancer. We aimed to estimate the prevalence of past and present HBV infection, susceptibility to HBV infection, and vaccine-induced immunity to hepatitis B among the US population during 2013-2018. APPROACH AND RESULTS: Prevalence estimates and 95% CIs were analyzed using 2013-2018 data from the National Health and Nutrition Examination Survey. Serologic testing among noninstitutionalized persons aged ≥ 6 years was used for classifying persons as total hepatitis B core antibody (anti-HBc), indicative of current or previous (ever having had) HBV infection; HBsAg, indicative of current HBV infection; and antibody to ABsAg (anti-HBs), indicative of immunity attributable to hepatitis B vaccination. Persons who tested negative for anti-HBc, HBsAg, and anti-HBs were considered susceptible to HBV infection. Non-US-born residents accounted for 69.1% of the population with chronic HBV infection and were 9.1 times more likely to be living with chronic hepatitis B, compared with US-born persons. Among adults aged ≥ 25 years who resided in US households, an estimated 155.8 million persons (or 73.4%) were susceptible to HBV infection, and an estimated 45.4 million had vaccine-induced immunity to hepatitis B. Men who have sex with men (MSM) were 3.6 times more likely to have ever been infected with HBV; however, MSM were just as likely to have vaccine-induced immunity to hepatitis B as non-MSM. CONCLUSION: Despite increasing immune protection among young persons vaccinated after birth, the estimated prevalence of persons living with chronic hepatitis B in the USA has remained unchanged at 0.3% since 1999.
引用
- Roberts H, Ly KN, Yin S, et al. Prevalence of HBV Infection, Vaccine-Induced Immunity, and Susceptibility Among At-Risk Populations: US Households, 2013-2018. Hepatology. 2021. PMID: 34097776. doi:10.1002/hep.31991
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。